carbachol has been researched along with Cardiomyopathy, Chagas in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sterin-Borda, L | 1 |
| Joensen, L | 1 |
| Bayo-Hanza, C | 1 |
| Esteva, M | 1 |
| Borda, E | 1 |
1 other study available for carbachol and Cardiomyopathy, Chagas
| Article | Year |
|---|---|
Therapeutic use of muscarinic acetylcholine receptor peptide to prevent mice chagasic cardiac dysfunction.
Topics: Amino Acid Sequence; Animals; Atrial Function; Carbachol; CD8-Positive T-Lymphocytes; Chagas Cardiom | 2002 |